{"id":7029,"date":"2017-05-05T15:36:18","date_gmt":"2017-05-05T19:36:18","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/new-jersey-law-journal-quotes-hunter-shkolnik-diabetes-drug-lawsuit\/"},"modified":"2017-05-05T15:36:18","modified_gmt":"2017-05-05T19:36:18","slug":"new-jersey-law-journal-alinti-avci-shkolnik-diyabet-uyusturucu-dava","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/new-jersey-law-journal-alinti-avci-shkolnik-diyabet-uyusturucu-dava\/","title":{"rendered":"NJ Law Journal, Hunter&#039;dan Diyabet Uyu\u015fturucu Davas\u0131 Hakk\u0131nda Al\u0131nt\u0131 Yap\u0131yor"},"content":{"rendered":"<p>Nisan 2016&#039;da ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), isimler alt\u0131nda sat\u0131lan diyabet ilac\u0131 saksagliptin \u00fczerinde daha g\u00fc\u00e7l\u00fc kalp sorunu uyar\u0131lar\u0131na ihtiya\u00e7 duyuldu\u011funu duyurdu. <a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/onglyza\/\">onglyza<\/a> \u00a0ve Kombigleze XR. \u0130la\u00e7 \u015firketlerinin kendileri taraf\u0131ndan y\u00fcr\u00fct\u00fclen 2015 tarihli bir \u015firket i\u00e7i ara\u015ft\u0131rma, saksagliptin kullan\u0131m\u0131ndan sonra kalp yetmezli\u011fi nedeniyle hastaneye yat\u0131\u015f oranlar\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 buldu. Daha \u00f6nceki bir FDA b\u00fclteni, diyabet ila\u00e7 geli\u015ftiricilerini \u00fcr\u00fcnlerinin kardiyak riskleri art\u0131rmad\u0131\u011f\u0131n\u0131 g\u00f6stermeye \u00e7a\u011f\u0131rm\u0131\u015ft\u0131.<\/p>\n<p>Uyu\u015fturucu \u00fcreticileri AstraZeneca Pharmaceuticals ve Bristol-Myers Squibb \u015fu anda New Jersey B\u00f6lgesinde saksagliptin kullan\u0131c\u0131lar\u0131n\u0131n ilac\u0131 kullanman\u0131n bir sonucu olarak y\u00fcksek kalp yetmezli\u011fi riskleriyle kar\u015f\u0131 kar\u015f\u0131ya kald\u0131klar\u0131n\u0131 iddia eden davalarla kar\u015f\u0131 kar\u015f\u0131ya. Davalar, Onglyza ve Kombigleze XR&#039;nin kalp durmas\u0131na, konjestif kalp yetmezli\u011fine ve hatta \u00f6l\u00fcme yol a\u00e7abilece\u011fini iddia ediyor. Ayr\u0131ca, ila\u00e7 \u015firketlerinin bu sorunlar\u0131 bildiklerini ancak sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131na ve hastalara haber vermediklerini belirtiyor.<\/p>\n<p><a href=\"\/wp-content\/uploads\/5-3-17-NJLJ-Drugmakers-Face-Suits-Linking-Diabetes-Med-to-Heart-Failure.pdf\">New Jersey Hukuk Dergisi<\/a>\u00a0yak\u0131n zamanda sorulan ortak <a href=\"\/tr\/napoli-attorney\/avci-shkolnik\/\">Avc\u0131 Shkolnik <\/a>&quot;Ki\u015finin daha \u00f6nce ne kadar sa\u011fl\u0131kl\u0131 oldu\u011funa ba\u011fl\u0131 olarak&quot; y\u00fcksek olabilece\u011fini yan\u0131tlad\u0131\u011f\u0131 vakalar\u0131n bireysel de\u011feri hakk\u0131nda. Ne yaz\u0131k ki on d\u00f6rt davaya dahil olan davac\u0131lar\u0131n hepsinde konjestif kalp yetmezli\u011fi veya kardiyak semptomlar var, birka\u00e7 vaka \u00f6len saksagliptin kullan\u0131c\u0131lar\u0131 \u00fczerine a\u00e7\u0131lm\u0131\u015ft\u0131r.<\/p>\n<p>Hunter ayr\u0131ca, davan\u0131n hem eyalet hem de federal d\u00fczeyde koordine edilmesini bekledi\u011fini a\u00e7\u0131klad\u0131; \u00fclke \u00e7ap\u0131nda bekleyen yakla\u015f\u0131k 200 kadar saksagliptin vakas\u0131 var. Bu say\u0131n\u0131n potansiyel olarak binlere \u00e7\u0131kabilece\u011fini s\u00f6yledi.<\/p>","protected":false},"excerpt":{"rendered":"<p>Nisan 2016&#039;da ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), Onglyza ve Kombigleze XR isimleri alt\u0131nda sat\u0131lan diyabet ilac\u0131 saksagliptin \u00fczerinde daha g\u00fc\u00e7l\u00fc kalp sorunu uyar\u0131lar\u0131na ihtiya\u00e7 duyuldu\u011funu duyurdu\u2026.<\/p>","protected":false},"author":3,"featured_media":7030,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[858],"class_list":["post-7029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-hunter-shkolnik"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/7029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=7029"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/7029\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/7030"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=7029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=7029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=7029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}